BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 19478132)

  • 1. Diacylglycerol acyltransferase 1 inhibition lowers serum triglycerides in the Zucker fatty rat and the hyperlipidemic hamster.
    King AJ; Segreti JA; Larson KJ; Souers AJ; Kym PR; Reilly RM; Zhao G; Mittelstadt SW; Cox BF
    J Pharmacol Exp Ther; 2009 Aug; 330(2):526-31. PubMed ID: 19478132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ragaglitazar: a novel PPAR alpha PPAR gamma agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models.
    Chakrabarti R; Vikramadithyan RK; Misra P; Hiriyan J; Raichur S; Damarla RK; Gershome C; Suresh J; Rajagopalan R
    Br J Pharmacol; 2003 Oct; 140(3):527-37. PubMed ID: 12970088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis.
    Yen CL; Stone SJ; Koliwad S; Harris C; Farese RV
    J Lipid Res; 2008 Nov; 49(11):2283-301. PubMed ID: 18757836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of diacyl glycerol acyl transferase (DGAT) inhibitors from Pachydictyon coriaceum.
    Choi BW; Lee HS; Lee KB; Lee BH
    Phytother Res; 2011 Jul; 25(7):1041-5. PubMed ID: 21254273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the mechanism of action of a DGAT1 inhibitor using a causal reasoning platform.
    Enayetallah AE; Ziemek D; Leininger MT; Randhawa R; Yang J; Manion TB; Mather DE; Zavadoski WJ; Kuhn M; Treadway JL; des Etages SA; Gibbs EM; Greene N; Steppan CM
    PLoS One; 2011; 6(11):e27009. PubMed ID: 22073239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference lowers triglyceride levels.
    Lim GB
    Nat Rev Cardiol; 2024 Jun; ():. PubMed ID: 38849676
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo efficacy of acyl CoA: diacylglycerol acyltransferase (DGAT) 1 inhibition in rodent models of postprandial hyperlipidemia.
    King AJ; Segreti JA; Larson KJ; Souers AJ; Kym PR; Reilly RM; Collins CA; Voorbach MJ; Zhao G; Mittelstadt SW; Cox BF
    Eur J Pharmacol; 2010 Jul; 637(1-3):155-61. PubMed ID: 20385122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) with small molecule inhibitors for the treatment of metabolic diseases.
    Cao J; Zhou Y; Peng H; Huang X; Stahler S; Suri V; Qadri A; Gareski T; Jones J; Hahm S; Perreault M; McKew J; Shi M; Xu X; Tobin JF; Gimeno RE
    J Biol Chem; 2011 Dec; 286(48):41838-41851. PubMed ID: 21990351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting DGAT1 Ameliorates Glioblastoma by Increasing Fat Catabolism and Oxidative Stress.
    Cheng X; Geng F; Pan M; Wu X; Zhong Y; Wang C; Tian Z; Cheng C; Zhang R; Puduvalli V; Horbinski C; Mo X; Han X; Chakravarti A; Guo D
    Cell Metab; 2020 Aug; 32(2):229-242.e8. PubMed ID: 32559414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic reprogramming by Zika virus provokes inflammation in human placenta.
    Chen Q; Gouilly J; Ferrat YJ; Espino A; Glaziou Q; Cartron G; El Costa H; Al-Daccak R; Jabrane-Ferrat N
    Nat Commun; 2020 Jun; 11(1):2967. PubMed ID: 32528049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential intracellular management of fatty acids impacts on metabolic stress-stimulated glucose uptake in cardiomyocytes.
    Vanni E; Lindner K; Gavin AC; Montessuit C
    Sci Rep; 2023 Sep; 13(1):14805. PubMed ID: 37684349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma.
    Zhou J; Simon JM; Liao C; Zhang C; Hu L; Zurlo G; Liu X; Fan C; Hepperla A; Jia L; Tcheuyap VT; Zhong H; Elias R; Ye J; Henne WM; Kapur P; Nijhawan D; Brugarolas J; Zhang Q
    Mol Cell; 2022 Aug; 82(16):3030-3044.e8. PubMed ID: 35764091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress from DGAT1 oncoprotein inhibition in melanoma suppresses tumor growth when ROS defenses are also breached.
    Wilcock DJ; Badrock AP; Wong CW; Owen R; Guerin M; Southam AD; Johnston H; Telfer BA; Fullwood P; Watson J; Ferguson H; Ferguson J; Lloyd GR; Jankevics A; Dunn WB; Wellbrock C; Lorigan P; Ceol C; Francavilla C; Smith MP; Hurlstone AFL
    Cell Rep; 2022 Jun; 39(12):110995. PubMed ID: 35732120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of novel thienopyrimidine derivatives as diacylglycerol acyltransferase 1 (DGAT-1) inhibitors.
    Hong DJ; Jung SH; Kim J; Jung D; Ahn YG; Suh KH; Min KH
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):227-234. PubMed ID: 31752563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PF-04620110, a Potent Antidiabetic Agent, Suppresses Fatty Acid-Induced NLRP3 Inflammasome Activation in Macrophages.
    Jo SI; Bae JH; Kim SJ; Lee JM; Jeong JH; Moon JS
    Diabetes Metab J; 2019 Oct; 43(5):683-699. PubMed ID: 31694081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Per os colchicine administration in cholesterol fed rabbits: Triglycerides lowering effects without affecting atherosclerosis progress.
    Kaminiotis VV; Agrogiannis G; Konstantopoulos P; Androutsopoulou V; Korou LM; Vlachos IS; Dontas IA; Perrea D; Iliopoulos DC
    Lipids Health Dis; 2017 Sep; 16(1):184. PubMed ID: 28950870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docosahexaenoic acid increases accumulation of adipocyte triacylglycerol through up-regulation of lipogenic gene expression in pigs.
    Huang CW; Chen YJ; Yang JT; Chen CY; Ajuwon KM; Chen SE; Su NW; Chen YS; Mersmann HJ; Ding ST
    Lipids Health Dis; 2017 Feb; 16(1):33. PubMed ID: 28173868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acyl-CoA:Diacylglycerol Acyltransferase 1 Expression Level in the Hematopoietic Compartment Impacts Inflammation in the Vascular Plaques of Atherosclerotic Mice.
    Vujic N; Porter Abate J; Schlager S; David T; Kratky D; Koliwad SK
    PLoS One; 2016; 11(5):e0156364. PubMed ID: 27223895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling the role of deacylation-reacylation in the lymphatic transport of a triglyceride-mimetic prodrug.
    Han S; Hu L; Quach T; Simpson JS; Trevaskis NL; Porter CJ
    Pharm Res; 2015 May; 32(5):1830-44. PubMed ID: 25446770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestine-targeted DGAT1 inhibition improves obesity and insulin resistance without skin aberrations in mice.
    Tsuda N; Kumadaki S; Higashi C; Ozawa M; Shinozaki M; Kato Y; Hoshida K; Kikuchi S; Nakano Y; Ogawa Y; Furusako S
    PLoS One; 2014; 9(11):e112027. PubMed ID: 25405858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.